Terra et al. found that CRP, IL-6, and IL-17 were significantly higher in patients with newly type 2 diabetes compared to those in nondiabetic obese patients and normal healthy subjects, and A-FABP was positively correlated with CRP and IL-6 in obese subjects with newly diagnosed type 2 diabetes [17]. This evidence concerns the gene IL6 and type 2 diabetes mellitus.